Communiqués Nolato AB London S.E.

Actions

0OA9

SE0015962477

Chimie de spécialité

Temps réel estimé Cboe Europe 09:55:31 08/10/2026			Varia. 5j.	Varia. 1 janv.
55,45 ^SEK	-4,48%		+7,50%	-5,15%

07:34	Nordea relève l’objectif de cours de Nolato à 69 couronnes et réitère son conseil d’achat	FW
07:25	Nordea relève l’objectif de cours de Nolato à 69 couronnes (60), réitère sa recommandation d’achat	FW

Communiqués

02/10	Nolato strengthens its offering through selective acquisitions and continued portfolio development	AQ
01/09	Nolato : acquires Dutch Unitron - strengthens the total customer offering in the Medical Solutions business area	PU
01/09	Nolato acquires Dutch Unitron – strengthens the total customer offering in the Medical Solutions business area	AQ
10/08	Nolato acquires Irish M&M Qualtech – strengthens the customer offering with scalable capacity in the electronics field	AQ
17/07	Nolato : Growth for both business areas and strong financial position ( investor relations investor information financial reports and presentations 2026 growth for both business areas and strong financial position )	PU
17/07	Nolato : Growth for both business areas and strong financial position	PU
10/07	Webcast conference call on July 17 about Nolato’s interim report for Q2 2026	AQ
29/06	Nolato divests its Romanian operations	AQ
24/05	Nolato appoints Anders Björklund as new President and CEO	AQ
13/05	Nolato : Transcript ( files mfn reports 2022 10 27 earnings call q3 2022)	PU
13/05	Nolato : Transcript ( files mfn reports 2026 05 06 earnings call q1 2026)	PU
06/05	Press release from the Annual General Meeting in Nolato AB (publ) 6 May 2026	AQ
06/05	Nolato : Earnings Call Q1 2026	PU
06/05	Nolato : Earnings Call Q1 2026 (engelska)	PU
06/05	Nolato : Analyst Presentation Q1 2026	PU
06/05	Nolato : Q1 2026 Interim Report	PU
06/05	Volume growth, stable margins and strong financial position	AQ
29/04	Webcast conference call on May 6 about Nolato’s interim report for Q1 2026	AQ
09/04	Nolato : Annual Report 2025	PU
09/04	Nolato publishes the annual report for 2025	AQ
05/02	Nolato : Q4 2025 Year End Report	PU
05/02	Nolato : Analyst Presentation Q4 2025	PU
05/02	Increased growth for Medical Solutions and strong financial position	AQ
30/01	New number of shares and votes in Nolato AB (publ)	AQ
29/01	Nolato's nomination committee proposes Gunilla Saltin and Martin Malmvik as new board members	AQ